JP2014507153A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014507153A5 JP2014507153A5 JP2013554425A JP2013554425A JP2014507153A5 JP 2014507153 A5 JP2014507153 A5 JP 2014507153A5 JP 2013554425 A JP2013554425 A JP 2013554425A JP 2013554425 A JP2013554425 A JP 2013554425A JP 2014507153 A5 JP2014507153 A5 JP 2014507153A5
- Authority
- JP
- Japan
- Prior art keywords
- he4a
- antibody
- polypeptide
- protein
- wfdc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/025321 WO2012112160A1 (en) | 2011-02-17 | 2011-02-17 | Compositions and methods of use for determination of he4a |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014507153A JP2014507153A (ja) | 2014-03-27 |
| JP2014507153A5 true JP2014507153A5 (enExample) | 2014-05-29 |
| JP5887364B2 JP5887364B2 (ja) | 2016-03-16 |
Family
ID=46672864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013554425A Active JP5887364B2 (ja) | 2011-02-17 | 2011-02-17 | HE4aの測定のための組成物および使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9822169B2 (enExample) |
| EP (1) | EP2675911B1 (enExample) |
| JP (1) | JP5887364B2 (enExample) |
| KR (3) | KR101854110B1 (enExample) |
| CN (1) | CN103492582B (enExample) |
| AU (1) | AU2011359350B2 (enExample) |
| BR (1) | BR112013021056B1 (enExample) |
| CA (1) | CA2827618C (enExample) |
| ES (1) | ES2834617T3 (enExample) |
| IL (1) | IL227924B (enExample) |
| RU (1) | RU2650778C2 (enExample) |
| WO (1) | WO2012112160A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7270960B2 (en) * | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
| ES2834617T3 (es) * | 2011-02-17 | 2021-06-18 | Fujirebio Diagnostics Inc | Composiciones y métodos de uso para la determinación de HE4a |
| CN106432492A (zh) * | 2015-08-07 | 2017-02-22 | 广州瑞博奥生物技术有限公司 | 针对肿瘤标志物建立的抗体组合及其elisa方法 |
| JP6613490B2 (ja) * | 2016-02-19 | 2019-12-04 | 国立大学法人 宮崎大学 | 腺癌の検出方法 |
| USD922352S1 (en) | 2019-01-04 | 2021-06-15 | Dolby Laboratories Licensing Corporation | Speaker |
| JP7539369B2 (ja) * | 2019-04-02 | 2024-08-23 | 大塚製薬株式会社 | 病態情報生成方法、病態情報生成システム、he4糖鎖分析キット及びhe4 |
| CN111620939B (zh) * | 2019-10-25 | 2021-01-01 | 南京市妇幼保健院 | 一种用于治疗或辅助治疗卵巢癌的多肽zyx36-58 |
| USD940793S1 (en) * | 2019-11-22 | 2022-01-11 | Microsoft Corporation | Electronic device |
| JPWO2021261483A1 (enExample) * | 2020-06-23 | 2021-12-30 | ||
| US20240353411A1 (en) * | 2022-04-08 | 2024-10-24 | Ajou University Industry-Academic Cooperation Foundation | He4 detecting peptide and use thereof |
| CN117487018B (zh) * | 2023-09-27 | 2024-05-17 | 武汉爱博泰克生物科技有限公司 | 抗人附睾分泌蛋白4的兔单克隆抗体及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5391485A (en) | 1985-08-06 | 1995-02-21 | Immunex Corporation | DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues |
| US7270960B2 (en) * | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
| PL1620082T3 (pl) * | 2003-05-05 | 2010-10-29 | Probiodrug Ag | Medyczne zastosowanie inhibitorów cyklazy glutaminylowej i glutaminianowej do leczenia choroby Alzheimera i zespołu Downa |
| JP4744109B2 (ja) | 2004-07-20 | 2011-08-10 | トヨタ自動車株式会社 | 半導体装置とその製造方法 |
| US7553944B2 (en) * | 2004-07-21 | 2009-06-30 | The University Of Hong Kong | Human virus causing respiratory tract infection and uses thereof |
| ATE408828T1 (de) * | 2005-02-16 | 2008-10-15 | Dana Farber Cancer Inst Inc | Verfahren zur erkennung eines ovarialkarzinoms |
| US20070286865A1 (en) | 2006-01-04 | 2007-12-13 | Richard Moore | Use of HE4 and other biochemical markers for assessment of ovarian cancers |
| JP2009524438A (ja) * | 2006-01-27 | 2009-07-02 | トライパス イメージング インコーポレイテッド | 卵巣癌を有する可能性の高い患者を同定するための方法およびそのための組成物 |
| EP2121761A1 (en) * | 2007-03-09 | 2009-11-25 | Tripath Imaging, Inc. | He4 monoclonal antibodies and methods for their use |
| US8455189B2 (en) | 2007-03-29 | 2013-06-04 | Jeffrey W. Allard | Use of HE4 for assessment of breast cancers |
| MX2013002268A (es) * | 2010-08-26 | 2014-02-03 | Univ Washington Ct Commerciali | Metodos para detectar anticuerpos anti-he4 y metodos de diagnosis y/o de prognosis de condiciones asociadas con celulas que expresan he4. |
| ES2834617T3 (es) * | 2011-02-17 | 2021-06-18 | Fujirebio Diagnostics Inc | Composiciones y métodos de uso para la determinación de HE4a |
| WO2012170513A2 (en) * | 2011-06-06 | 2012-12-13 | Women & Infants' Hospital Of Rhode Island | He4 based therapy for malignant disease |
-
2011
- 2011-02-17 ES ES11858800T patent/ES2834617T3/es active Active
- 2011-02-17 RU RU2013142334A patent/RU2650778C2/ru active
- 2011-02-17 KR KR1020137024824A patent/KR101854110B1/ko active Active
- 2011-02-17 JP JP2013554425A patent/JP5887364B2/ja active Active
- 2011-02-17 CA CA2827618A patent/CA2827618C/en active Active
- 2011-02-17 CN CN201180070210.2A patent/CN103492582B/zh active Active
- 2011-02-17 EP EP11858800.3A patent/EP2675911B1/en active Active
- 2011-02-17 WO PCT/US2011/025321 patent/WO2012112160A1/en not_active Ceased
- 2011-02-17 BR BR112013021056-7A patent/BR112013021056B1/pt active IP Right Grant
- 2011-02-17 US US13/985,983 patent/US9822169B2/en active Active
- 2011-02-17 KR KR1020207002847A patent/KR20200013118A/ko not_active Ceased
- 2011-02-17 KR KR1020187002826A patent/KR102074141B1/ko active Active
- 2011-02-17 AU AU2011359350A patent/AU2011359350B2/en active Active
-
2013
- 2013-08-12 IL IL227924A patent/IL227924B/en active IP Right Grant
-
2017
- 2017-10-19 US US15/788,389 patent/US20180057575A1/en not_active Abandoned
-
2020
- 2020-07-01 US US16/918,503 patent/US20200325215A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2827618C (en) | Compositions and methods of use for the determination of he4a | |
| CN114539411A (zh) | 一种ror1抗体或其抗原结合片段 | |
| CN113272332B (zh) | 抗Claudin18.2的抗体及其应用 | |
| JP2024500512A (ja) | 抗b7-h3抗体およびその使用 | |
| CN115433277B (zh) | 抗cd38兔重组单克隆抗体的制备及应用 | |
| JP3996649B2 (ja) | 腫瘍関連抗原に対するモノクローナル抗体、その製造方法およびその使用 | |
| CN113880948B (zh) | 抗ca724抗体或其抗原结合片段及其制备方法和应用 | |
| JP2022124478A (ja) | 成人スティル病の検査方法及び検査キット | |
| JP6967523B2 (ja) | Aimp2−dx2タンパク質に特異的に結合する抗体 | |
| CN118027205B (zh) | 特异性结合crept的抗体及其用途 | |
| TWI782000B (zh) | 抗gpr20抗體、其製造方法及其應用 | |
| CN113527481B (zh) | 抗人nkx3.1单克隆抗体及其制备方法和应用 | |
| CN119562972A (zh) | 抗cd20抗体的单克隆抗体及其应用 | |
| JP2024513880A (ja) | 免疫組織化学法およびkir3dl2特異的薬剤 | |
| JP5956424B2 (ja) | 抗体、乳がんの治療に用いられる医薬組成物、腫瘍検査方法、及び、腫瘍検査用試薬 | |
| CN115785273A (zh) | 一种抗胃蛋白酶原i的抗体及其应用 | |
| CN114430747A (zh) | 抗csf-1r抗体 | |
| CN119462920B (zh) | 抗p16蛋白抗体及其制备方法和应用 | |
| CN114213542B (zh) | Cps-i抗体及其用途 | |
| KR102688094B1 (ko) | Cobll1 단백질 특이 항체 또는 이의 항원 결합 단편, 및 이의 용도 | |
| WO2022268200A1 (zh) | 针对密蛋白18.2的抗体及其用途 | |
| WO2025218662A1 (zh) | 抗成纤维细胞生长因子受体2b的抗体及其用途 | |
| JP2024544961A (ja) | 抗cldn18.2モノクローナル抗体およびその使用 | |
| KR20250122027A (ko) | 고양이 혈청 아밀로이드 a 단백질에 대한 단일클론항체, 이를 생산하는 융합 세포주 및 이의 용도 | |
| KR20250122026A (ko) | 고양이 혈청 아밀로이드 a 단백질에 대한 단일클론항체, 이를 생산하는 융합 세포주 및 이의 용도 |